Fig. 1
![Fig. 1](http://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12885-018-3999-0/MediaObjects/12885_2018_3999_Fig1_HTML.gif)
CT scans. Evaluation CT scans before start of pazopanib (a) and 12 weeks after start of pazopanib (so 6 weeks on pazopanib and 6 weeks off because of liver toxicity) (b) showing a shrinking pulmonary metastasis measured by largest diameter at both times